Poster | An deep plasma workflow applied discover biomarker candidates of response to chemo-immunotherapy in patients with thoracic malignancies

A deep plasma workflow applied to discover biomarker candidates of response to chemo-immunotherapy in patients with thoracic malignancies

Poster presented at ASMS 2024, Anaheim (CA)

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although immunotherapy has improved the treatment of NSCLC, a significant number of patients still fail to respond or develop resistance.

Back to Resources overview

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More